it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.. september 2010 (16). (image: rex/shutterstock). taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.. the comments below have not been moderated. . advertisement .
the comments below have not been moderated.
by continuing to use this site you consent to the use of cookies on your device as described in our.